These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15081249)

  • 1. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains.
    Papenfuss TL; Rogers CJ; Gienapp I; Yurrita M; McClain M; Damico N; Valo J; Song F; Whitacre CC
    J Neuroimmunol; 2004 May; 150(1-2):59-69. PubMed ID: 15081249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
    Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
    J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of quantitative trait loci controlling cortical motor evoked potentials in experimental autoimmune encephalomyelitis: correlation with incidence, onset and severity of disease.
    Mazón Peláez I; Vogler S; Strauss U; Wernhoff P; Pahnke J; Brockmann G; Moch H; Thiesen HJ; Rolfs A; Ibrahim SM
    Hum Mol Genet; 2005 Jul; 14(14):1977-89. PubMed ID: 15917267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinduction of experimental autoimmune encephalomyelitis in mice.
    Lindsey JW; Pappolla M; Steinman L
    Cell Immunol; 1995 May; 162(2):235-40. PubMed ID: 7538049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis.
    Uboldi C; Döring A; Alt C; Estess P; Siegelman M; Engelhardt B
    Eur J Immunol; 2008 Aug; 38(8):2156-67. PubMed ID: 18651702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice.
    Encinas JA; Lees MB; Sobel RA; Symonowicz C; Greer JM; Shovlin CL; Weiner HL; Seidman CE; Seidman JG; Kuchroo VK
    J Immunol; 1996 Sep; 157(5):2186-92. PubMed ID: 8757345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-related effects of fenbendazole treatment on murine experimental autoimmune encephalomyelitis.
    Ramp AA; Hall C; Orian JM
    Lab Anim; 2010 Jul; 44(3):271-3. PubMed ID: 20457828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis.
    Teuscher C; Butterfield RJ; Ma RZ; Zachary JF; Doerge RW; Blankenhorn EP
    J Immunol; 1999 Aug; 163(4):2262-6. PubMed ID: 10438970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice.
    Butterfield RJ; Sudweeks JD; Blankenhorn EP; Korngold R; Marini JC; Todd JA; Roper RJ; Teuscher C
    J Immunol; 1998 Aug; 161(4):1860-7. PubMed ID: 9712054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
    Boullerne AI; Polak PE; Braun D; Sharp A; Pelligrino D; Feinstein DL
    J Neurochem; 2014 May; 129(4):696-703. PubMed ID: 24471474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early handling increases susceptibility to experimental autoimmune encephalomyelitis (EAE) in C57BL/6 male mice.
    Columba-Cabezas S; Iaffaldano G; Chiarotti F; Alleva E; Cirulli F
    J Neuroimmunol; 2009 Jul; 212(1-2):10-6. PubMed ID: 19493575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
    Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
    J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
    Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
    J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase.
    Emerson MR; LeVine SM
    Brain Res; 2004 Sep; 1021(1):140-5. PubMed ID: 15328042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.